Effect of magnesium treatment and glucose levels on delayed cerebral ischemia in patients with subarachnoid hemorrhage: a substudy of the Magnesium in Aneurysmal Subarachnoid Haemorrhage trial (MASH-II)

High glucose variability increases cerebral infarction in patients with spontaneous subarachnoid hemorrhage

(2013) Jeffrey F. Barletta et al.   JOURNAL OF CRITICAL CARE

Magnesium for aneurysmal subarachnoid haemorrhage (MASH-2): a randomised placebo-controlled trial

(2012) Sanne M Dorhout Mees et al.   LANCET

Diabetes Mellitus and Risk of Stroke and Its Subtypes Among Japanese

(2011) Renzhe Cui et al.   STROKE

Definition of Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage as an Outcome Event in Clinical Trials and Observational Studies

(2010) Mervyn D.I. Vergouwen et al.   STROKE

In Search of Clinical Neuroprotection After Brain Ischemia

(2009) Bruno P. Meloni et al.   STROKE

Results of the MRI Substudy of the Intravenous Magnesium Efficacy in Stroke Trial

(2009) Chelsea S. Kidwell et al.   STROKE

Combined magnesium and mild hypothermia (35 °C) treatment reduces infarct volumes after permanent middle cerebral artery occlusion in the rat at 2 and 4, but not 6 h

(2008) Kym Campbell et al.   BRAIN RESEARCH

Magnesium treatment and spontaneous mild hypothermia after transient focal cerebral ischemia in the rat

(2008) Kym Campbell et al.   BRAIN RESEARCH BULLETIN

High mean fasting glucose levels independently predict poor outcome and delayed cerebral ischaemia after aneurysmal subarachnoid haemorrhage

(2008) N D Kruyt et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY